Baxter International is gearing up to report its third-quarter results later this month, and analysts anticipate a sharp ...
Baxter (BAX) rated Hold with a $25 target and 2.6% upside. BAX trades at a discount to the sector. See here for a detailed ...
Fintel reports that on 7 October 2026, Barclays initiated coverage of Baxter International (LSE:0QK8) with a Underweight recommendation. This initiation follows a prior action on 4 May 2026, when ...
Fintel on MSN
Barclays initiates coverage of Baxter International Inc. - depositary receipt at underweight
Fintel reports that on October 7, 2026, Barclays initiated coverage of Baxter International Inc. - Depositary Receipt (BOVESPA:B1AX34) with a Underweight recommendation. This action on October 7, 2026 ...
CARE Pharmacies Cooperative announced that its CEO, Mike Wysong, has been elected by the Board of Directors of the National ...
Unverified AI tools and data leaks are creating new vulnerabilities for healthcare organizations, underscoring the need for ...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time.
With as many as 80% of partnerships facing failure, leaders need to be self-reflective about why they want to pursue an ...
Baxter International has an average rating of hold and mean price target of $26.82, according to analysts polled by FactSet. Price: 24.17, Change: -0.20, Percent Change: -0.80 ...
What are Medical IV Fluid Bags?Medical IV fluid bags are medical containers used to hold sterile solutions such as saline, ...
Baxter International stock costs EUR 21.27 on October 8, 2026 after EUR 21.57. Becton Dickinson NYSE Börsenparkett mit ...
Muted Q3 (est. +4.8% profits) before a stronger 2027 outlook; Bloomberg Intelligence forecasts a 13% gain by Q1 as launches, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results